Product Name :
Uric acid sodium
Description:
Uric acid sodium, scavenger of oxygen radical, is a very important antioxidant that help maintains the stability of blood pressure and antioxidant stress. Uric acid sodium can remove reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, inhibiting lipid peroxidation.
CAS:
1198-77-2
Molecular Weight:
191.10
Formula:
C5H4N4NaO3
Chemical Name:
2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione sodium
Smiles :
[Na].O=C1NC(=O)NC2NC(=O)NC1=2 |^1:0|
InChiKey:
XDKLKFULWJYRCB-UHFFFAOYSA-N
InChi :
InChI=1S/C5H4N4O3.Na/c10-3-1-2(7-4(11)6-1)8-5(12)9-3;/h(H4,6,7,8,9,10,11,12);
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life:
≥12 months if stored properly.
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.
Additional information:
Uric acid sodium, scavenger of oxygen radical, is a very important antioxidant that help maintains the stability of blood pressure and antioxidant stress. Uric acid sodium can remove reactive oxygen species (ROS) such as singlet oxygen and peroxynitrite, inhibiting lipid peroxidation.|Product information|CAS Number: 1198-77-2|Molecular Weight: 191.10|Formula: C5H4N4NaO3|Chemical Name: 2,3,6,7,8,9-hexahydro-1H-purine-2,6,8-trione sodium|Smiles: [Na].{{Chamaejasmenin A} site|{Chamaejasmenin A} Immunology/Inflammation|{Chamaejasmenin A} Protocol|{Chamaejasmenin A} Purity|{Chamaejasmenin A} custom synthesis|{Chamaejasmenin A} Epigenetics} O=C1NC(=O)NC2NC(=O)NC1=2 |^1:0||InChiKey: XDKLKFULWJYRCB-UHFFFAOYSA-N|InChi: InChI=1S/C5H4N4O3.{{Certolizumab pegol} medchemexpress|{Certolizumab pegol} Apoptosis|{Certolizumab pegol} Biological Activity|{Certolizumab pegol} In Vitro|{Certolizumab pegol} manufacturer|{Certolizumab pegol} Autophagy} Na/c10-3-1-2(7-4(11)6-1)8-5(12)9-3;/h(H4,6,7,8,9,10,11,12);|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Solubility: DMSO : 5 mg/mL (26.PMID:32180353 30 mM; ultrasonic and warming and adjust pH to 6 with HCl and heat to 80°C).|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vitro:|Uric acid (400 μM; 48 hours) protects Caco-2 cells from indomethacin-induced lipid peroxidation. Co-treatment of cells with Indomethacin and Uric acid (200 μM IND plus 400 μM UA; 24 hours) significantly decreases ROS levels compared to those in cells incubated with indomethacin alone. Cell viability in Caco-2 cells treated with both Indomethacin and Uric acid (200 μM IND plus 400 μM UA; 24 hours) is higher than that in cells treated with indomethacin alone. Uric acid has a protective effect on indomethacin-induced intestinal cell changes through its antioxidant activity.|In Vivo:|Uric acid (250 mg/kg; p.o.) ameliorates indomethacin-induced enteropathy. Oral administration of uric acid decreased ROS accumulation in the ileum in a mouse model of indomethacin-induced enteropathy.|Products are for research use only. Not for human use.|
